Structure Therapeutics (GPCR) Current Assets (2022 - 2026)

Structure Therapeutics' Current Assets history runs 5 years deep, the most recent figure standing at $1.5 billion for Q1 2026.

• In Q1 2026, Current Assets rose 75.44% year-over-year to $1.5 billion; the TTM figure through Mar 2026 stood at $1.5 billion (up 75.44% YoY), while the FY2025 annual figure was $1.6 billion, up 76.2% from the prior year.
• Current Assets for Q1 2026 stood at $1.5 billion, down from $1.6 billion in the prior quarter.
• The five-year high for Current Assets was $1.6 billion in Q4 2025, with the low at $93.1 million in Q4 2022.
• The 5-year median for Current Assets is $806.7 million (2025), against an average of $712.6 million.
• The sharpest annual moves came in 2023 and 2025: Current Assets soared 408.77% in 2023, then dropped 14.75% in 2025.
• Structure Therapeutics' Current Assets stood at $93.1 million in 2022, then jumped by 408.77% to $473.6 million in 2023, then jumped by 88.17% to $891.2 million in 2024, then jumped by 76.2% to $1.6 billion in 2025, then slipped by 5.08% to $1.5 billion in 2026.
• Business Quant data shows GPCR's Current Assets at $1.5 billion in Q1 2026, $1.6 billion in Q4 2025, and $814.0 million in Q3 2025.